论文部分内容阅读
我院1998年11月～1999年12月试用胆维他片治疗脂肪肝58例,并设对照组进行观察,收到良好效果,报告如下。 1 临床资料 1.1本组共114例,均为消化内科门诊病人,其中男75例。女39例,年龄27～73岁,平均45.4岁,病史最短半年。最长13年,平均4.26年,临床表现为不同程度的上腹不适、胀闷、食欲不振、肝脏肿大等。病因:慢性嗜酒72例,单纯肥胖28例,糖尿病14例;实验室检查均有不同程度的肝功能异常,血酯升高,并排除病毒性肝炎及胆系疾病。 1.2 将114例随机分为治疗组58例和对照组56例,两组的年龄、性别、病情及实验室指标相仿,具有可比性(P>0.05),治疗组予胆维他片50mg,一日3次口服。对照组予
Our hospital from November 1998 to December 1999 trial of gallbladder tablets treatment of fatty liver in 58 cases, and the control group were observed, received good results, the report is as follows. 1 Clinical data 1.1 This group a total of 114 cases, are gastroenterology outpatients, including 75 males. Female 39 cases, aged 27 to 73 years, an average of 45.4 years old, the shortest history of six months. Up to 13 years, an average of 4.26 years, the clinical manifestations of varying degrees of abdominal discomfort, bloating, loss of appetite, enlargement of the liver. Etiology: 72 cases of chronic alcoholism, simple obesity in 28 cases, 14 cases of diabetes; laboratory tests have varying degrees of liver dysfunction, elevated blood levels, and rule out viral hepatitis and biliary diseases. 1.2 The 114 patients were randomly divided into treatment group 58 cases and 56 cases of control group, the two groups of age, sex, illness and laboratory indicators are comparable (P> 0.05) 3 times daily oral. The control group was given